These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7992444)
21. Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Fernández Guerrero ML; González López JJ; Goyenechea A; Fraile J; de Górgolas M Medicine (Baltimore); 2009 Jan; 88(1):1-22. PubMed ID: 19352296 [TBL] [Abstract][Full Text] [Related]
22. Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Chu VH; Miro JM; Hoen B; Cabell CH; Pappas PA; Jones P; Stryjewski ME; Anguera I; Braun S; Muñoz P; Commerford P; Tornos P; Francis J; Oyonarte M; Selton-Suty C; Morris AJ; Habib G; Almirante B; Sexton DJ; Corey GR; Fowler VG; Heart; 2009 Apr; 95(7):570-6. PubMed ID: 18952633 [TBL] [Abstract][Full Text] [Related]
23. Endocarditis with pericardial bioprostheses: clinico-pathologic characteristics, immediate and long term prognosis. Gonzalez-Juanatey JR; Garcia-Acuna JM; Garcia-Bengoechea J; Rubio J; Duran D; Sierra J; Fernandez-Vazquez F; Gil M J Heart Valve Dis; 1994 Mar; 3(2):172-8. PubMed ID: 8012635 [TBL] [Abstract][Full Text] [Related]
24. Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease. Miele PS; Kogulan PK; Levy CS; Goldstein S; Marcus KA; Smith MA; Rosenthal J; Croxton M; Gill VJ; Lucey DR Am Heart J; 2001 Oct; 142(4):571-6. PubMed ID: 11579344 [TBL] [Abstract][Full Text] [Related]
25. Management of prosthetic valve infective endocarditis. Hill EE; Herregods MC; Vanderschueren S; Claus P; Peetermans WE; Herijgers P Am J Cardiol; 2008 Apr; 101(8):1174-8. PubMed ID: 18394454 [TBL] [Abstract][Full Text] [Related]
26. Infections of prosthetic heart valves and cardiac pacemakers. Heimberger TS; Duma RJ Infect Dis Clin North Am; 1989 Jun; 3(2):221-45. PubMed ID: 2663979 [TBL] [Abstract][Full Text] [Related]
27. Outcome of patients requiring valve surgery during active infective endocarditis. Hill EE; Herregods MC; Vanderschueren S; Claus P; Peetermans WE; Herijgers P Ann Thorac Surg; 2008 May; 85(5):1564-9. PubMed ID: 18442538 [TBL] [Abstract][Full Text] [Related]
28. [Natural history and prognosis in infective endocarditis]. Tornos MP; Almirante B; Soler Soler J Rev Esp Cardiol; 1998; 51 Suppl 2():40-3. PubMed ID: 9658947 [TBL] [Abstract][Full Text] [Related]
29. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Chu VH; Woods CW; Miro JM; Hoen B; Cabell CH; Pappas PA; Federspiel J; Athan E; Stryjewski ME; Nacinovich F; Marco F; Levine DP; Elliott TS; Fortes CQ; Tornos P; Gordon DL; Utili R; Delahaye F; Corey GR; Fowler VG; Clin Infect Dis; 2008 Jan; 46(2):232-42. PubMed ID: 18171255 [TBL] [Abstract][Full Text] [Related]
30. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Tleyjeh IM; Ghomrawi HM; Steckelberg JM; Hoskin TL; Mirzoyev Z; Anavekar NS; Enders F; Moustafa S; Mookadam F; Huskins WC; Wilson WR; Baddour LM Circulation; 2007 Apr; 115(13):1721-8. PubMed ID: 17372170 [TBL] [Abstract][Full Text] [Related]
31. [Long-term results of the surgical treatment in acute aortic valve endocarditis]. Vogt PR; Brunner-LaRocca HP Z Kardiol; 2001; 90 Suppl 6():27-34. PubMed ID: 11826819 [TBL] [Abstract][Full Text] [Related]
32. Influence of pathogenetic factors on prognosis in patients with native valve infective endocarditis. Abramczuk E; Hryniewiecki T; Stepińska J Kardiol Pol; 2006 Jul; 64(7):675-81; discussion 682-3. PubMed ID: 16886124 [TBL] [Abstract][Full Text] [Related]
34. Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Sohail MR; Martin KR; Wilson WR; Baddour LM; Harmsen WS; Steckelberg JM Am J Med; 2006 Feb; 119(2):147-54. PubMed ID: 16443417 [TBL] [Abstract][Full Text] [Related]
35. Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. Drinković D; Morris AJ; Pottumarthy S; MacCulloch D; West T J Antimicrob Chemother; 2003 Nov; 52(5):820-5. PubMed ID: 14519677 [TBL] [Abstract][Full Text] [Related]
36. Bloodstream infections in patients with implanted prosthetic cardiac valves. Gordon SM; Keys TF Semin Thorac Cardiovasc Surg; 1995 Jan; 7(1):2-6. PubMed ID: 7893832 [TBL] [Abstract][Full Text] [Related]
37. [Survey of infective endocarditis in the last 10 years: analysis of clinical, microbiological and therapeutic features]. Sekido M; Takano T; Takayama M; Hayakawa H J Cardiol; 1999 Apr; 33(4):209-15. PubMed ID: 10225203 [TBL] [Abstract][Full Text] [Related]
38. [Infectious endocarditis: morbi-mortality in Chile. Results of the National Cooperative Study of Infective Endocarditis (1998-2002)]. Oyonarte M; Montagna R; Braun S; Maiers E; Rojo P; Cumsille JF; Rev Med Chil; 2003 Mar; 131(3):237-50. PubMed ID: 12790072 [TBL] [Abstract][Full Text] [Related]